AI Article Synopsis
- The study aimed to gather real-life data on how ibrutinib is used and its safety profiles in patients between November 2014 and November 2018.
- A total of 102 patients participated, mainly receiving ibrutinib for chronic lymphocytic leukemia (CLL), with 47.1% experiencing serious adverse drug reactions (SADRs) within the first year.
- The findings highlighted that older patients (aged ≥80) and those with CLL had a higher risk of developing SADRs, indicating that they require closer monitoring during treatment.
Article Abstract
Aims: To provide real-life data on patterns of use and safety of ibrutinib.
Methods: A cohort study including all patients initiating ibrutinib between 21 November 2014 and 21 November 2018, and followed for 1 year was conducted. Patient characteristics, ibrutinib use and adverse drug reactions (ADRs) were collected from medical records. Kaplan-Meier analysis estimated the probability of developing ibrutinib-associated serious ADRs (SADRs) with a 95% confidence interval (CI). A Cox proportional hazards model was used to investigate factors associated with SADR occurrence.
Results: In total, 102 patients were included in the study. The median age was 70.3 years (interquartile range 64.7-75.6), the male/female gender ratio was 2.9. Almost half the patients (47.1%) were prescribed ibrutinib for chronic lymphocytic leukaemia (CLL). Forty-three patients (42.1%) permanently discontinued ibrutinib in the first year, mostly for progression (51.2%) or ADRs (32.6%). Forty-eight patients (47.1%) experienced at least one ibrutinib-associated SADR. Haematological, infectious and vascular disorders were the most frequent SADRs. The probability of developing ibrutinib-associated SADR was 35.1% (95% CI 26.3-45.7%) at 3 months, 44.8% (35.2%; 55.8%) at 6 months and 54.3% (44.0%; 65.2%) at 12 months. Age ≥80 years (hazard ratio [HR] 2.03; 95% CI 1.02-4.05) and CLL (HR 1.81; 95% CI 1.01-3.25) were significantly associated with a higher risk of SADR occurrence.
Conclusion: This study found a high cumulative incidence of ibrutinib-associated SADRs within the first year of treatment. In view of the risk of SADR, patients aged ≥80 years or treated for CLL deserve special attention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bcp.14440 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing the aquaticity level in healthy adolescents. A randomized control study.
Front Sports Act Living
December 2024
Department of PE and Sports Science, School of Physical Education, Sport Science and Dietetics, University of Thessaly, Volos, Greece.
Unlabelled: Aquaticity is an important parameter of human aquatic performance and behavior and can be objectively assessed by the aquaticity assessment test. Low aquaticity score can unveil a person's high risk in the water while it could dictate the specific characteristics that need to be addressed or developed for improving water competence.
Aim: The aim of the current study was to assess whether human aquaticity can be developed by systematic exercise and which type of training is more effective in improving aquaticity score.
Prevalence of Depression in Older Adults and the Potential Protective Role of Volunteering: Findings From the LongROAD Study.
J Am Geriatr Soc
January 2025
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Background: As the US population continues to age, depression and other mental health issues have become a significant challenge for healthy aging. Few studies, however, have examined the prevalence of depression in community-dwelling older adults in the United States.
Methods: Baseline data from the Longitudinal Research on Aging Drivers study were analyzed to examine the prevalence and correlates of depression in a multisite sample of community-dwelling adults aged 65-79 years who were enrolled and assessed between July 2015 and March 2017.
Backward swimming in elongated-bodied abyssal demersal fishes: Synaphobranchidae, Macrouridae, and Ophidiidae.
J Fish Biol
January 2025
Minderoo-UWA Deep-Sea Research Centre, School of Biological Sciences and Oceans Institute, The University of Western Australia, Perth, Western Australia, Australia.
The deep-sea demersal fish fauna is characterized by a prevalence of elongated-body forms with long tapering tails. Using baited camera landers at depths of 4500-6300 m in the Pacific Ocean, we observed multiple instances of backward swimming using reverse undulation of the slender body in four species: the cutthroat eel Ilyophis robinsae, abyssal grenadier Coryphaenoides yaquinae, and cusk-eels Bassozetus sp. and Barathrites iris.
View Article and Find Full Text PDFTornado sheltering: Challenges and solutions including public storm shelters.
J Emerg Manag
January 2024
Department of Geosciences, Mississippi State University, Mississippi State, Mississippi.
Tornadoes are a considerable threat across the United States, occurring in many regions of the country on a frequent basis throughout the year. Finding a safe place to go during a tornado can be a challenge for many individuals, and, in some situations, there is no safe place available. Increasing the number of tornado shelters and establishing them in regions where they are not currently present can greatly improve the safety of local residents and visitors, especially for those who are unable to afford retrofitting a shelter into their own home or business.
View Article and Find Full Text PDFMedicare Part D: Major Shifts With the Inflation Reduction Act and a Way Forward.
J Am Geriatr Soc
January 2025
Borun Center, Division of Geriatrics, University of California Los Angeles, Los Angeles, California, USA.
The Inflation Reduction Act (IRA) of 2022 introduced major changes in the Part D benefit that aim to improve medication access and correct several of the financial misalignments in the current Part D benefit. The changes address financial obligations of Medicare beneficiaries, the federal government, Part D plan sponsors (i.e.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!